XNYS · BMY

-3.72% · -$2.21 · Vol 14.1M

Market closed · last close 4:00 PM ET · price as of 19:40:59 ET

Bristol-Myers Squibb Co.

PHARMACEUTICAL PREPARATIONS

$57.13

+ Add to watchlist

Card

Relationship Map

Veridion Score

Refresh

Score snapshot refresh in progress

Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS

HISTORY WINDOW BUILDING

AI Analysis

Sovereign

Why is BMY moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.

Catalyst calendar

What can move BMY next.

Earnings, ratings, disclosures, volume, and score-history events. Every row needs a dated receipt.

Congress / Score

Upcoming

No dated upcoming catalyst is present in the current source window.

Recent

Jul 14
Score
Score moved +17
53/NEUTRAL -> 70/BUY BIAS
Veridion score historySource
Jul 6
CongressSovereign
Ro Khanna sale disclosed
Disclosure detail is available inside Sovereign and Reserve.
STOCK Act filingUnlock receipt
Jun 11
CongressSovereign
Mike Kelly sale disclosed
Disclosure detail is available inside Sovereign and Reserve.
STOCK Act filingUnlock receipt
Jun 11
CongressSovereign
Mike Kelly sale disclosed
Disclosure detail is available inside Sovereign and Reserve.
STOCK Act filingUnlock receipt
Jun 11
CongressSovereign
Hon. Mike Kelly sale disclosed
Disclosure detail is available inside Sovereign and Reserve.
STOCK Act filingUnlock receipt
Jun 9
CongressSovereign
Ro Khanna purchase disclosed
Disclosure detail is available inside Sovereign and Reserve.
STOCK Act filingUnlock receipt
May 11
CongressSovereign
Ro Khanna purchase disclosed
Disclosure detail is available inside Sovereign and Reserve.
STOCK Act filingUnlock receipt
Mar 9
CongressSovereign
Ro Khanna purchase disclosed
Disclosure detail is available inside Sovereign and Reserve.
STOCK Act filingUnlock receipt
Feb 6
CongressSovereign
Ro Khanna sale disclosed
Disclosure detail is available inside Sovereign and Reserve.
STOCK Act filingUnlock receipt

Catalyst calendar

Dated receipts for BMY are being assembled.

About Bristol-Myers Squibb Co.

PHARMACEUTICAL PREPARATIONS

Listed since

1952

Employees

33K

Country

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.

Company website →

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open

$59.00

Day high

$59.14

Day low

$56.78

Previous close

$59.34

52W high

$59.14

-3.40% from high

52W low

$56.78

15% of range

Market cap

$121.2B

P/E

16.23×

EPS

$3.52

Shares out

Volume

14.1M

VWAP

$57.55

Price history computed in-house

-0.78%

SMA 50 $57.61 · below

SMA 200 $57.61 · below

52W position 15%

Veridion warehouse edge

Warehouse intelligence for BMY.

Veridion Score

0: 661: 762: 493: 554: 635: 70

Congress 30d

Ro Khanna · Sale

Insider activity

See Form 4 panel below.

13F holders

None on file

Capital Web snapshots checked.

Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.

Related public evidence

Relationship mapTrace receipt-backed holders and filings around BMY.Congress disclosuresOpen receipt and filing context for BMY.MethodologyReview score inputs, coverage rules, and limitations.

Data ledger

Quote and day range

Refresh interval: 30 seconds

Source: Market data

Veridion Score

Coverage building

Source: Veridion methodology

Chart and risk context

Daily bars with no missing-bar fill

Source: Market data

News and filings

Refresh intervals shown inside each panel

Source: Market news and federal filings

Financials

Statements refresh in progress

SEC Form 4 ledger

BMY insider activity

Bristol-Myers Squibb Co.

Score

Coverage building

Pressure

Mixed

Filings

Buys / sells

0 / 0

Net value

Not disclosed

Insiders

Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for BMY.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology

Congress · 90D

Congress filing snapshot refresh in progress

Federal contracts

BMY contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed

Refresh interval: 12hSource: Federal contract awards

No federal contracts on file for BMY in this window.

Lobbying spend

BMY lobbying filings, year to date.

Registered lobbying filings matched to Bristol-Myers Squibb Co..

$2.8M

Refresh interval: 12hSource: LDA disclosure filings

Health Issues Medicare/Medicaid Taxation/Internal Revenue Code Copyright/Patent/Trademark Trade (domestic/foreign)Medicare/MedicaidHealth Issues Medicare/Medicaid Trade (domestic/foreign) Pharmacy

Filing

$1.3M

BRISTOL-MYERS SQUIBB COMPANY

Apr 20, 2026

Filing

$1.3M

BRISTOL-MYERS SQUIBB COMPANY

Jan 20, 2026

Filing

$80.0K

BRISTOL-MYERS SQUIBB

THE MCMANUS GROUP